KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $39.6 million.

  • Medpace Holdings' Change in Accured Expenses rose 124153.95% to $39.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $97.1 million, marking a year-over-year increase of 47506.81%. This contributed to the annual value of $97.1 million for FY2025, which is 47506.81% up from last year.
  • Medpace Holdings' Change in Accured Expenses amounted to $39.6 million in Q4 2025, which was up 124153.95% from $45.3 million recorded in Q3 2025.
  • Medpace Holdings' 5-year Change in Accured Expenses high stood at $45.3 million for Q3 2025, and its period low was -$23.2 million during Q1 2025.
  • For the 5-year period, Medpace Holdings' Change in Accured Expenses averaged around $13.7 million, with its median value being $16.2 million (2022).
  • In the last 5 years, Medpace Holdings' Change in Accured Expenses plummeted by 47159.93% in 2021 and then soared by 124153.95% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Change in Accured Expenses stood at $1.5 million in 2021, then soared by 215.9% to $4.6 million in 2022, then soared by 486.8% to $27.2 million in 2023, then tumbled by 89.14% to $2.9 million in 2024, then surged by 1241.54% to $39.6 million in 2025.
  • Its Change in Accured Expenses stands at $39.6 million for Q4 2025, versus $45.3 million for Q3 2025 and $35.4 million for Q2 2025.